RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler treatment tested for frail myeloma patients
Disease control OngoingThis study is testing a combination of three drugs for multiple myeloma that has returned or stopped responding to prior treatments. It specifically aims to see if using lower doses of two of the drugs is safe and effective for older patients or those who are too frail for standa…
Matched conditions: RELAPSE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Gene-Edited immune cells take aim at Virus-Linked cancer
Disease control OngoingThis study is testing a new cell therapy for lymphoma that has come back after treatment and is linked to Epstein-Barr virus (EBV). Researchers are giving patients special immune cells (T cells) that have been genetically modified to resist a substance released by the tumor and t…
Matched conditions: RELAPSE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC